Abstract
Proteinuria is a recognized complication of morbid obesity, although it develops only in a minority of patients. Renal biopsies and autopsy studies have shown that focal and segmental glomerulosclerosis (FSG) is the commonest histologic lesion in proteinuric obese patients [1]. Obesity‐related FSG can be distinguished from idiopathic cases of FSG by glomerulomegaly and by less severe foot process effacement. From a clinical point of view, patients with obesity‐related glomerulopathies (ORG) do not develop the nephrotic syndrome (hypoalbuminaemia, oedema) even when there is massive and sustained proteinuria. This clinical characteristic (that is also observed in other renal diseases related to hyperfiltration such as reflux nephropathy or proteinuria related to renal mass reduction) is very useful to distinguish these patients from idiopathic FSG in which a complete nephrotic syndrome usually accompanies the presence of nephrotic‐range proteinuria [2]. The reasons why patients with ORG do not develop complete nephrotic syndrome remain unexplained but may relate to differences in the tubular management of filtered proteins and in a very slow proteinuria increase over the years which is characteristic of ORG and other hyperfiltering disorders.